S.133 - PATIENTS Act of 2013

A bill to protect all patients by prohibiting the use of data obtained from comparative effectiveness research to deny or delay coverage of items or services under Federal health care programs and to ensure that comparative effectiveness research accounts for advancements in personalized medicine and differences in patient treatment response. view all titles (3)

All Bill Titles

  • Short: PATIENTS Act of 2013 as introduced.
  • Official: A bill to protect all patients by prohibiting the use of data obtained from comparative effectiveness research to deny or delay coverage of items or services under Federal health care programs and to ensure that comparative effectiveness research accounts for advancements in personalized medicine and differences in patient treatment response. as introduced.
  • Short: Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2013 as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Bill’s Views

  • Today: 1
  • Past Seven Days: 3
  • All-Time: 528
 
Introduced
 
Senate
Passes
 
House
Passes
 
President
Signs
 

 
01/24/13
 
 
 
 
 
 
 

Sponsor

Senator

Pat Roberts

R-KS

View Co-Sponsors (7)

Official Summary

Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2013 or PATIENTS Act of 2013 - Prohibits the Secretary of Health and Human Services (HHS) from using data obtained from comparative effectiveness research, including any conducted or s

Official Summary

Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2013 or PATIENTS Act of 2013 - Prohibits the Secretary of Health and Human Services (HHS) from using data obtained from comparative effectiveness research, including any conducted or supported using funds appropriated under the American Recovery and Reinvestment Act of 2009 (ARRA) or authorized or appropriated under the Patient Protection and Affordable Care Act, to deny or delay coverage of an item or service under a federal health care program. Requires the Secretary to ensure that comparative effectiveness research conducted or supported by the federal government accounts for factors contributing to differences in the treatment response and preferences of patients, including patient-reported outcomes, genomics and personalized medicine, the unique needs of health disparity populations, and indirect patient benefits.

...Read the Rest


Latest Letters to Congress

See All Letters (1)
 


Vote on This Bill

67% Users Support Bill

2 in favor / 1 opposed
 

Send Your Senator a Letter

about this bill Support Oppose Tracking
Track with MyOC